Dividend stocks have long been a cornerstone for boosting investor returns, and a recent analysis by Morgan Stanley suggests that several companies are strategically positioned to initiate payouts, potentially leading to significant gains. Strategist Todd Castagno highlighted in a note that companies initiating a regular, quarterly dividend have historically delivered outsized returns, outperforming the broader market by an average of 650 basis points in the six months following the announcement and a remarkable 1,000 basis points in the subsequent 12-month period. This performance is in addition to the long-term benefits of compounding returns through dividend reinvestment.
The average initial dividend yield for companies initiating payouts typically hovers around 2.0%, with Consumer Staples, Utilities, and Energy sectors generally offering the highest initial yields, while Information Technology, Industrials, and Consumer Discretionary sectors tend to have lower starting yields. Morgan Stanley's team identified potential 'dividend hopefuls' by screening for companies that currently do not offer a quarterly dividend, possess net cash exceeding 5% of their market capitalization, and exhibit a free cash flow yield greater than 5%.
Among the companies making this select list is Centene, which boasts an impressive 18% free cash flow yield. The health insurer has also garnered attention from investors like David Einhorn of Greenlight Capital, who sees potential benefits from AI automation in streamlining its operations. Centene recently surpassed earnings and revenue expectations for its first quarter and raised its full-year guidance, contributing to a 44% rise in its stock year-to-date.
BioMarin Pharmaceutical also met the criteria with a 10.4% free cash flow yield and a net cash position equivalent to 7.6% of its market cap. Following its recent $4.8 billion acquisition of Amicus Therapeutics, BioMarin has expanded its portfolio of treatments for rare metabolic diseases, including key drugs for Fabry and Pompe diseases. While the acquisition led to a slight adjustment in non-GAAP earnings guidance, it significantly boosted revenue forecasts for the full year, projecting between $3.825 to $3.925 billion. Despite a 6% year-to-date decline, the strategic expansion positions BioMarin for future growth.
Duolingo, despite a nearly 36% drop in its stock this year, also appeared on the radar. The language-learning app provider recently exceeded revenue and EBITDA expectations for its first quarter. However, its daily and monthly active user numbers fell short of analyst estimates, although the company maintains an ambitious target of reaching 100 million daily active users by 2028, prioritizing user growth and improved teaching methods.
Lastly, Deckers Outdoor, the parent company of Hoka and Ugg brands, reported strong fiscal first-quarter earnings. With a 6.7% free cash flow yield, the company is recognized by analysts like Peter McGoldrick of Stifel for its category-defining brands, growth potential, and strong return metrics. Deckers Outdoor has seen a nearly 10% increase in its stock value this year.
